Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-EN Version v9-EN
Language English English
Date Updated 2021-06-17 2020-12-10
Drug Identification Number 02254727 02254727
Brand name ACT TERBINAFINE ACT TERBINAFINE
Common or Proper name TERBINAFINE 250MG TABLET TERBINAFINE 250MG TABLET
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TERBINAFINE TERBINAFINE
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code D01BA D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE ANTIFUNGALS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-08 2020-04-08
Estimated end date 2021-10-31 2021-02-28
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Item is to be discontinued - Transitioned
Health Canada comments